Paper Review Records
全部论文审稿周期
22 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
258
天
Anthropometric traits, metabolic biomarkers, and pancreatic cancer risk: a causal mediation analysis in UK Biobank
作者
Amina Amadou; Heinz Freisling; Benoit Mercoeur; Patricia Bohmann; Michael J. Stein; Hwayoung Noh; Alem Gebremariam; Anja M. Sedlmeier; Laia Peruchet-Noray; Quan Gan; Michael F. Leitzmann; Hansjörg Baurecht; Béatrice Fervers展开收起
作者单位
1. Department of Prevention Cancer Environment, Centre Léon Bérard, Lyon, France; 2. Inserm U1296 Radiations: Defense, Health, Environment, Lyon, France; 3. International Agency for Research on Cancer (IARC), Nutrition and Metabolism Branch, Lyon, France; 4. Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany; 5. Center for Translational Oncology, University Hospital Regensburg, Regensburg, Germany展开收起
343
天
TP53 mutation-biased CD8 + T cell exhaustion drives lethal outcome and therapy resistance in urothelial carcinoma
作者
Xiaohe Su; Kaifeng Jin; Han Zeng; Zhaopei Liu; Lingkai Zhang; Yawei Ding; Jiaxing Sun; Yuzhen Wu; Hailong Liu; Yuan Chang; Le Xu; Weijuan Zhang; Zewei Wang; Yu Zhu; Jiejie Xu展开收起
作者单位
1. Shanghai Urothelial Carcinoma Research Group (SUCRG), National Health Commission Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China; 2. Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China; 3. Department of Urology, Urologic Surgery Center, Xinqiao Hospital, Third Military Medical University (Army Medical University), Chongqing, China; 4. Department of Urology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; 5. Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China; 6. Department of Urology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 7. Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China展开收起
78
天
A national survey of UK Family History services
作者
Thomas J. E. Hubbard; Jon Coleman Reed; Sumohan Chatterjee; Helen Hanson; Ramsey Cutress展开收起
作者单位
1. Faculty of Health and Life Sciences, University of Exeter, Exeter, UK; 2. Prevent Breast Cancer, Manchester, UK; 3. Manchester University Foundation NHS Trust, Manchester, UK; 4. University of Southampton, Southampton, UK展开收起
105
天
Paediatric Therapeutic Development Workshop on rhabdomyosarcoma
作者
Joseph S. Baxter; Claudia Montiel Equihua; Jan J. Molenaar; Jamie Aye; Gianni Bisogno; Patricia Blanc; Willemijn Breunis; Julia Chisholm; Jacquelyn Crane; Sam Daems; Laura Danielson; Bram de Wilde; Adam D. Durbin; Felipe Galvez-Cancino; Patrizia Gasparini; Birgit Geoerger; Simone Graham; Bass Hassan; Mark E. Hatley; Delphine Heenen; Christine M. Heske; Simone Hettmer; Elizabeth Hookham; Peter Houghton; Pamela Kearns; Charles Keller; Javed Khan; Fiona Kinnis; David Langenau; Geffen Lass; Corinne Mary Linardic; Leo Mascarenhas; Michael T. Meister; Jonathan Metts; Véronique Minard-Colin; Sapna Oberoi; Daniela Palacios; Abbe Pannucci; Seema Patel; Sheena Patel; Silvia Pomella; Terry Rabbitts; Rossella Rota; Erin Rudzinski; Beat Schäfer; John Jack Shern; Karin Straathof; Rajkumar Venkatramani; Marco Wachtel; Sara Wakeling; Zoë Walters; Sam Warburton; Brenda Weigel; Andrew D. J. Pearson; David Jenkinson; Janet Shipley; Michela Casanova展开收起
作者单位
1. LifeArc, London, UK; 2. Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; 3. The University of Alabama at Birmingham, Birmingham, USA; 4. Department of Women’s and Children’s Health, University of Padova and Pediatric Hematology Oncology Unit, University Hospital of Padova, Padua, Italy; 5. Imagine for Margo, Paris, France; 6. University Children’s Hospital Zurich, Zürich, Switzerland; 7. The Royal Marsden Hospital and Institute of Cancer Research, Sutton, UK; 8. Children’s Hospital of Philadelphia, Philadelphia, USA; 9. Waterland Private Equity Investments, Antwerp, Belgium; 10. I3h Institute, Université libre de Bruxelles, Brussels, Belgium; 11. Cancer Research UK, London, UK; 12. Ghent University Hospital, Gent, Belgium; 13. St Jude Children’s Research Hospital, Memphis, USA; 14. Laboratory of Immune-Regulation, Centre for Immuno-Oncology, Nuffield Department of Medicine, University of Oxford, Oxford, UK; 15. Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy; 16. Gustave Roussy, Paris, France; 17. Sir William Dunn School of Pathology, University of Oxford, Oxford, UK; 18. KickCancer Foundation, Brussels, Belgium; 19. Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, USA; 20. Pediatrics I, Martin-Luther University Halle-Wittenberg, Halle, Germany; 21. UT Health San Antonio, San Antonio, USA; 22. College of Medicine and Health, University of Birmingham, Birmingham, UK; 23. Innovative Therapies for Children and Adolescents with Cancer (ITCC), Paris, France; 24. Children’s Cancer Therapy Development Institute, Hillsboro, USA; 25. Oncogenomics Section, Genetics Branch, Centre for Cancer Research, National Cancer Institute, Bethesda, USA; 26. Massachusetts General Hospital - Charlestown Navy Yard (CNY) Campus, Charlestown, USA; 27. Department of Pediatrics, Duke University School of Medicine, LSRC, Durham, USA; 28. Cedars Sinai, Los Angeles, USA; 29. Johns Hopkins All Children’s Cancer & Blood Disorders Institute, Saint Petersburg, USA; 30. Max Rady College of Medicine, Pediatrics and Child Health, CancerCare Manitoba, University of Manitoba, Winnipeg, Canada; 31. Institute for Systems Analysis and Computer Science “Antonio Ruberti” (IASI), National Research Council (CNR), Rome, Italy; 32. Alice’s Arc, New York City, USA; 33. Cancer Research Horizons, London, UK; 34. Bambino Gesu’ Children’s Hospital, IRCCS, Rome, Italy; 35. The Institute of Cancer Research, Brookes Lawley Building, Centre for Cancer Drug Discovery, Sutton, UK; 36. Indiana University School of Medicine, Indianapolis, USA; 37. Universitäts-Kinderspital Zürich, Eleonorenstiftung, Zürich, Switzerland; 38. Cancer Research, National Cancer Institute, Bethesda, USA; 39. University College London Cancer Institute, Great Ormond Street Biomedical Research Centre, London, UK; 40. Texas Children’s Hospital, Houston, USA; 41. Alice’s Ark, Children’s Cancer Charity, Sevenoaks, UK; 42. Southampton General Hospital, University of Southampton, Southampton, UK; 43. The Institute of Cancer Research, London, UK展开收起
44
天
Risk-based breast cancer screening
作者
Stig Egil Bojesen展开收起
作者单位
1. Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; 2. Department of Clinical Biochemistry, Copenhagen University Hospital, Herlev Gentofte, Copenhagen, Denmark展开收起
137
天
Next-generation models for lymphoid malignancies: the rise of 3D culture systems in translational hematology
作者
Narimène Houmera; Laurent Genestier; Sarah Huet展开收起
作者单位
1. Team Lymphoma Immuno-Biology, Centre International de Recherche en Infectiologie, Lyon, France; 2. Institut des Sciences Pharmaceutiques et Biologiques, Université Claude Bernard Lyon 1, Lyon, France; 3. Service d’hématologie biologique, Hôpital Lyon Sud, Hospices Civils de Lyon, Lyon, France展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天